Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Nidan Laboratories and Healthcare IPO is a fixed price issue of Rs 50.00 crores.
Nidan Laboratories and Healthcare IPO bidding started from October 28, 2021 and ended on November 2, 2021. The allotment for Nidan Laboratories and Healthcare IPO was finalized on Tuesday, November 9, 2021. The shares got listed on NSE SME on November 12, 2021.
Nidan Laboratories and Healthcare IPO price is ₹125 per share. The minimum lot size for an application is 1000 Shares. The minimum amount of investment required by retail investors is ₹125,000.
First Overseas Capital Limited is the book running lead manager of the Nidan Laboratories and Healthcare IPO, while Bigshare Services Pvt Ltd is the registrar for the issue.
Refer to Nidan Laboratories and Healthcare IPO RHP for detailed information.
| IPO Date | October 28, 2021 to November 2, 2021 |
| Listing Date | November 12, 2021 |
| Face Value | ₹10 per share |
| Price | ₹125 per share |
| Lot Size | 1000 Shares |
| Total Issue Size | 4,000,000 shares (aggregating up to ₹50.00 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Market Maker portion | 200,000 shares |
Nidan Laboratories and Healthcare IPO offers 4,000,000 shares. 1,900,000 (47.50%) to NII, 1,900,000 (47.50%) to RII.
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | - |
| Market Maker Shares Offered | 200,000 (5.00%) |
| Other Shares Offered | 1,900,000 (47.50%) |
| Retail Shares Offered | 1,900,000 (47.50%) |
| Total Shares Offered | 4,000,000 (100%) |
Nidan Laboratories and Healthcare IPO opens on October 28, 2021, and closes on November 2, 2021.
| IPO Open Date | Thursday, October 28, 2021 |
| IPO Close Date | Tuesday, November 2, 2021 |
| Basis of Allotment | Tuesday, November 9, 2021 |
| Initiation of Refunds | Wednesday, November 10, 2021 |
| Credit of Shares to Demat | Thursday, November 11, 2021 |
| Listing Date | Friday, November 12, 2021 |
| Cut-off time for UPI mandate confirmation | 5 PM on November 2, 2021 |
Investors can bid for a minimum of 1000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1000 | ₹125,000 |
| Retail (Max) | 1 | 1000 | ₹125,000 |
| Lot Size Calculator | |||
Dr. Nithin Vitthalrao Thorave is the company promoter.
| Share Holding Pre Issue | 99.99% |
| Share Holding Post Issue | 71.22% |
Incorporated in the year 2000, Nidan Laboratories and Healthcare Limited offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. As of March 31, 2021, the company offered approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.
Nidan has come out with a unique appointment booking mobile application under the name of "NIDAN HEALTHCARE" which is supported by self-indigenous software called "Nidan Operation Management (NOM)." This unique app enables patients to book appointments for any test, from anywhere, at any time. The company has also tied up with pathology partners like Metropolis Laboratories Limited for its services.
Out of the 35 centers operating under the brand name of "Nidan Healthcare", 16 centers are under the Franchisee model where 1 center acts as a fully operated diagnostic center and 15 centers act solely as standalone collection centers. As of June 30, 2021, the company had a total of 213 employees. The company has got recognitions like the Best Diagnostic Chain of India Award 2019, in the Category of 20+ diagnostic centers by Express Healthcare.
Competitive Strengths:
| Particulars | For the year/period ended (₹ in Millions) | ||||
|---|---|---|---|---|---|
| 30-Jun-21 | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | ||
| Total Assets | 543.30 | 524.36 | 452.07 | 430.57 | |
| Total Revenue | 78.45 | 218.53 | 221.91 | 209.72 | |
| Profit After Tax | 10.87 | 23.02 | 7.14 | 2.23 | |
The net proceed from the IPO will be utilized towards the following purposes;
[Dilip Davda] For the last three fiscals, Nidan Laboratories top line remained static, but profit margins improved with a sharp rise for FY21. It has expressed similar trends for FY22 Q1, but the sustainability of such margins going forward is a major concern as the segment is highly fragmented and witnessing a cutthroat competition. Due to pandemics, these segments gained fancy and perhaps this company is trying to encase on this boom. Based on financial parameters the asking price is high. Hence there is no harm in ignoring this issue. Read detail review...
The Nidan Laboratories and Healthcare IPO is subscribed 1.80 times on November 2, 2021 5:00:00 PM. The public issue subscribed 3.44 times in the retail category, times in the QIB category, and 0.15 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| Other | 0.15 |
| Retail | 3.44 |
| Total | 1.80 |
| Listing Date | November 12, 2021 |
| BSE Script Code | |
| NSE Symbol | NIDAN |
| ISIN | INE0J6L01013 |
| Final Issue Price | ₹125 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| NSE SME |
|---|
| ₹125.00 |
| ₹123.90 |
| ₹117.75 |
| ₹123.90 |
| ₹117.75 |
Nidan Laboratories and Healthcare Limited
Swapnshilpa, Behind Aarti Apartment,
Vartak Road, Virar (West) – 401303,
Palagar, Maharashtra, India
Phone: +91 8975610000
Email: cs@nidanhealthcare.co.in
Website: https://nidanhealthcare.co.in/
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide 
Nidan Laboratories and Healthcare IPO is a SME IPO of 4,000,000 equity shares of the face value of ₹10 aggregating up to ₹50.00 Crores. The issue is priced at ₹125 per share. The minimum order quantity is 1000 Shares.
The IPO opens on October 28, 2021, and closes on November 2, 2021.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Nidan Laboratories and Healthcare IPO using UPI as a payment gateway. Zerodha customers can apply in Nidan Laboratories and Healthcare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Nidan Laboratories and Healthcare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Nidan Laboratories and Healthcare IPO opens on October 28, 2021 and closes on November 2, 2021.
Nidan Laboratories and Healthcare IPO lot size is 1000 Shares, and the minimum amount required is ₹125,000.
You can apply in Nidan Laboratories and Healthcare IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Nidan Laboratories and Healthcare IPO will be done on Tuesday, November 9, 2021, and the allotted shares will be credited to your demat account by Thursday, November 11, 2021. Check the Nidan Laboratories and Healthcare IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
IPO Guru (1400+ Posts, 1400+ Likes)
IPO Mentor (1600+ Posts, 400+ Likes)
